Caricamento...
mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
Metastasis is the biggest challenge in treating breast cancer, and it kills >40,000 breast cancer patients annually in the US. Aberrant expression of the RON receptor tyrosine kinase in breast tumors correlates with poor prognosis and has been shown to promote metastasis. However, the molecular m...
Salvato in:
| Pubblicato in: | NPJ Breast Cancer |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6226524/ https://ncbi.nlm.nih.gov/pubmed/30456298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-018-0091-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|